Farther Finance Advisors’s Aptose Biosciences, Inc. APTO Stock Holding History

Farther Finance Advisors’s Portfolio APTO Stock Details APTO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$15	Hold	10	–	–	﹤0.01%	5921
2026 Q1	$17	Hold	10	–	–	﹤0.01%	5666
2025 Q4	$15	Buy	+10	New	+$15	﹤0.01%	5408

Other funds holding APTO

Gleason Group Prospect, Kentucky $1.15B AUM 21.11% 1-Year Est. Return

Farther Finance Advisors's APTO Position: Q2 2026 in Review

Farther Finance Advisors held its Aptose Biosciences, Inc. (APTO) position steady in Q2 2026 at 10 shares worth $15. The position accounts for ﹤0.01% of the portfolio, ranked #5921.

Farther Finance Advisors first reported a position in APTO in Q4 2025 and has held it in 3 quarters since. The position peaked at $17 in Q1 2026. 2 funds tracked by Wall St. Rank hold APTO as of Q2 2026.

Farther Finance Advisors held 10 shares of Aptose Biosciences, Inc. worth $15 as of Q2 2026.
Farther Finance Advisors left its Aptose Biosciences, Inc. share count unchanged in Q2 2026.
Aptose Biosciences, Inc. made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #5921 holding.
Farther Finance Advisors first reported a position in Aptose Biosciences, Inc. in Q4 2025 and has held it in 3 quarters since.
Farther Finance Advisors's Aptose Biosciences, Inc. position peaked at $17 in Q1 2026.
2 funds tracked by Wall St. Rank held Aptose Biosciences, Inc. as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.